ABSTRACT
Introduction
The developmental process of neural induction is highly conserved among vertebrates. Early Xenopus embryos have been used as a model system to investigate the first steps of this important event. It has been suggested that neural induction results from the opposing action of ventralizing signals such as bone morphogenetic proteins (BMPs) from the ectoderm, which are responsible for the determination of the epidermis, and dorsalizing signals, such as noggin, chordin, follistatin, XnR3 and Cerberus, from the dorsal mesoderm. The molecular mechanisms driving neural specification depend partly on a context where BMP pathway is downregulated (review by Sasai and De Robertis 1997) .
However antagonizing BMP signalling is not sufficient to explain neural induction and other signalling pathways are necessary. In particular, in amphibian embryos during gastrulation transient elevations of internal calcium concentration ([Ca 2+ ]i) are restricted to the neural tissue precursor cells. These Ca 2+ transients require the activation of DHP-sensitive Ca 2+ channels (Leclerc et al., 1997; Leclerc et al., 2000) . Ectodermal explants (animal cap) isolated at blastula are multipotent cells and exhibit developmental plasticity. In the absence of an inducing signal, the ectodermal cells express markers specific to epidermis. However, in the presence of BMP antagonists, such as noggin, they express neural-specific markers. Using this assay we have shown that Ca 2+ signaling is a necessary and sufficient event to induce neural fate (reviewed in (Moreau et al., 2009) . Indeed, an artificial increase in [Ca 2+ ]i obtained by an entry of Ca 2+ through plasma membrane Ca 2+ channels or by caffeine, known to stimulate the release of Ca 2+ from internal stores, is sufficient to trigger the expression of proneural markers such as Pou2 within 30 minutes (Moreau and Leclerc 2004) but also the formation of neurons and glial cells (Moreau et al., 1994) . In order to identify new genes early transcribed after a Ca 2+ signal and involved in neural induction we have generated a subtractive cDNA library between untreated animal caps (i.e. fated to give epidermis) and caffeine-treated animal caps (i.e. fated to give neural tissue) (Batut et al., 2003) .
Among the Ca 2+ target genes isolated from the cDNA subtractive library and involved in neural induction (Batut et al., 2003; Batut et al., 2005) , a differentially expressed gene encoding a putative RNA-et al., 1996) . According to its sequence, the putative EFNA-2 is therefore renamed Xp54nrb, for Xenopus laevis 54 kDa nuclear RNA-binding protein.
Since Xp54nrb is isolated in a screen for Ca
2+
-responding genes, we confirmed by RT-PCR that the expression of Xp54nrb during neuralisation of animal caps depends on Ca 2+ signalling. Previously we have shown that the treatment of animal caps with the BMP antagonist noggin leads to a rapid and transient increase in [Ca 2+ ] i (Batut et al., 2005; Leclerc et al., 1997) . Therefore, animal caps prepared from stage 9 embryos are incubated for 30 min with 20 mM of BAPTA-AM prior to incubation with noggin (at 2 mg/mL) and then cultured to late gastrula (stage 12). RT-PCR analyses indicate that the expression of Xp54nrb is strongly reduced by BAPTA and
binding protein, initially annotated as EFNA-2-prov, and renamed Xp54nrb, is selected for further analysis. In this study, we establish that Xp54nrb expression is restricted to neural tissues during Xenopus embryogenesis, with a strong persistence in the anterior nervous system and in the visual structures. In addition Xp54nrb knockdown by specific morpholino leads to reduced expression of proneural markers in the anterior region of the neural plate. Xenopus early neural development using a cDNA subtractive library between short-time Ca
Results

Isolation
2+
-induced and non-induced ectoderms (Batut et al., 2003; Batut et al., 2005) together with a large-scale whole mount in situ hybridization, we identified a partial cDNA fragment (clone 3F4) that is exclusively present in the subtracted population issued from the neuralized ectoderms and totally absent from the subtracted non-induced population. The partial cDNA clone 3F4 is used as probe for in silico cDNA library screening and the corresponding cDNA is identified as a complete clone, with the initial annotation for encoding an EFNA-2 related as provisional sequence (accession number BC045128; (Klein et al., 2002) . Another clone sharing 98% identity in its nucleotide sequence is generated from a systematic screening library of Xenopus anterior structures (accession number AB238228; (Takahashi et al., 2005) .
As shown in Fig. 1 , the resulting 464 amino acidlong polypeptide contains two highly conserved RNA Recognition Motifs (RRM1 and RRM2), a QH-rich domain and an acidic/basic region characteristic of the RNA-binding protein (RBP) family. The alignment sequence across vertebrate species reveals that our clone is homologous to the non-POU-domain containing, octamer binding protein, NonO/p54nrb in mammalians (Dong et al., 1993) (i.e. 75% and 74% identity with Homo sapiens and Mus musculus respectively; Table1). The lowest similarity is with the Drosophila melanogaster NonA protein (Jones and Rubin 1990; Rendahl that the expression of the pan-neural marker Zic3 is completely abolished by BAPTA (Fig. 2, n=2 independent experiments).
Recently, it has been suggested that animal caps might have pre-neural or neural border character which leads to a reconsideration of the naive properties of this model (Linker et al., 2009) . To verify whether animal caps possess naïve properties in our hands we assayed the expression of Pax3, a marker of neural border character (Wills et al., 2010) . As shown on Fig. 2 , Pax3 expression is undetectable in non stimulated animal caps. In addition the induction of Pax3 expression by noggin protein is reduced when animal caps are pre-loaded with the calcium chelator BAPTA-AM. The prospective neural crest gene Slug (Mayor et al., 1995) is weakly expressed in control explants however, it remains transcribed after Noggin treatment even in the presence of BAPTA. No expression p54nrb/NonA nuclear localisation emanated from Drosophila immunohistochemistry assay (Rendahl et al., 1992) . A nuclear localisation sequence of p54nrb is carried by the C terminus domain, since its deletion implies the cytoplasmic retention of the truncated form (Zhang and Carmichael 2001) . In order to study the subcellular localisation of Xp54nrb, we have injected a synthetic Xp54nrb mRNA tagged with GFP (see experimental procedures). We have verified by western blot experiments that this tagged protein is expressed at gastrula stage embryo (Fig.3A) . As shown in Fig. 3B , the exogenous Xp54nrb-GFP tandem protein is effectively visualized within the nucleus of injected cells, whereas the GFP protein alone remains mainly cytoplasmic. To confirm this nuclear localisation, the embryos are cultivated in the presence of the DNA marker DRAQ5. Indeed, the Xp54nrb-GFP foci are ex- of the mesodermal marker Xbra is detected in these animal caps. These data strongly suggest that the induction of Xp54nrb expression in animal cap cells treated with the BMP antagonist noggin requires an increase in [Ca 2+ ] i .
Nuclear localisation of Xenopus Xp54nrb protein
Xp54nrb exhibits the RRM domains characteristic of RNA binding proteins, implicated in pre-mRNA splicing steps. This mechanism occurs within the nucleus and in mammalian cells in specialized nuclear structures (Fox et al., 2002) . The first indication of B C A clusively restricted to the DRAQ5-labeled nuclei (Fig. 3C, merge) . Taking into account that p54 proteins in Drosophila, mammals and diverse cell types (Amelio et al., 2007; Zhang et al., 2001; Rendahl et al., 1992) have nuclear localisation, our data suggest that the endogenous Xp54nrb protein is likely expressed in the nucleus of Xenopus ectodermal cells.
Maternal and zygotic expression pattern of Xp54nrb
The spatio-temporal expression of Xp54nrb was also determined. Xp54nrb mRNA, detected by RT-PCR, is present in all the stages tested, i.e., from stage 3 through to swimming larvae (Fig.  4) . The tissue-specific pattern of Xp54nrb transcript is revealed by whole-mount in situ hybridization. No staining at any stage is visible with the sense probe. Maternal expression is present at the animal pole and maintained during cleavage stages in the animal dorsal blastomeres (Fig. 5A , 5B; stage 3 and 6.5 respectively). After the midblastula transition (MBT), a faint labelling is detected in the ectodermal sheet, this labelling increases significantly during gastrulation in the dorsal ectoderm and mesoderm (Fig. 5C , stage 11). The gastrula sagittal section shown in Fig. 5D illustrates the expression of Xp54nrb in the ectoderm and in the involuting mesoderm. No labelling is observed in the endoderm. With subsequent development, the expression pattern of Xp54nrb becomes spatially restricted to the neural plate and then to the closing neural tube Rh; rhombencephalon, sm; somitic mesoderm, v; ventral. Scale bars 0.5 mm in (A, B), 0.3 mm in (C, D, E, G, H) Xp54nrb-GFP mRNA previously used (Fig. 3) inhibit the fusion protein expression in living embryos (Fig. 7B, left lower panel) , whereas control morpholino (MoC) or co-injection of MoXp54 with GFP mRNA have no effect on protein translation (Fig. 7B , right and left panels respectively). Thereby, MoXp54 is able to recognize the 5' sequence of the Xp54nrb messenger and therefore to efficiently block the translation of the Xp54nrb-GFP fusion transcript. We then targeted morpholino microinjections directed against Xp54nrb, in one dorsal blastomere at 4-cell stage, allowed the embryos to develop until stage 14 (neural plate) or stage 17 (neural fold stage) and analyzed the expression pattern of Zic3 (Nakata et al., 1997), POU2 (Witta et al., 1995) which are early proneural markers shown to be sensitive to Ca 2+ -induced neuralisation Leclerc et al., 2000) and of Sox2, a pre-neural marker gene expressed at the onset of neural induction downstream to the BMP4 antagonist Chordin (Mizuseki et al., 1998) and which is maintained in neural progenitors.
At stage 14, the expression of POU2 on the injected side is diminished at the anterior part of the neural plate (n = 8; 5 embryos with a decreased staining; Fig. 8B ), compared to the uninjected side or to control morpholino injected embryo (n = 8; 100% normal; Fig. 8A ). This impairment remains clearly visible at stage 17 as neural tube closure progresses (n = 30/39 embryos; Fig. 8D ), when POU2 mRNA strongly stains the mesencephalon-rhombencephalon boundary. The proneural gene Zic3 also shows a reduced expression level in the Xp54nrb knockdown side of stage 14 embryo (n = 16/22 embryos; Fig. 8F ). Zic3 expression pattern is also affected at stage 17 (n = 16/24 embryos; Fig. 8H ). Similarly, Sox2 staining is affected in the anterior domain of the MoXp54 injected side (n = 7/12 embryos with faded staining; Fig. 8J ). The effect at the anterior part of the brain anlagen is more clearly visible later at stage 17 (n = 19/23 embryos; Fig. 8L ). The reduced expressions also observed at stage 17 for Pou2, Zic3 and Sox2 indicate that Fig. 5F , transverse section). The Xp54nrb transcript is highly expressed in the anterior neural territories, involved in the regionalisation of the future brain structures and the eye anlagen (Fig. 5G, stage 21 , anterior view). The transcript is also located more caudally in the spinal cord as illustrated in the transverse section, whereas it is excluded from the notochord and the somitogenic mesoderm (Fig. 5H) . At stage 23, the staining is observed in the mesencephalon and in the eye vesicles, which invaginate from the diencephalic region. The prospective retinal layer and prospective pigment layer are both stained ( Fig. 6A and  B) . Later, during organogenesis at tailbud stages, robust expression is maintained in the anterior central nervous system and in the developing neuroretina (Fig. 6C, stage 35) . Other sensorial structures, such as the olfactory placodes, the otic vesicle, and the branchial arch derivatives are also labelled. Labelling is absent from the cement gland (Fig. 6C) . The associated anterior transverse section (Fig. 6E) shows the localised expression of Xp54nrb in the dorsal part of the encephalic epithelium, with a gradient of expression along the dorso-ventral axis. The entire overlying epidermis is free of staining. Section through the eye shows that Xp54nrb mRNA is specifically transcribed in the inner nuclear cell layer and ganglion cell layer (Fig. 6F) . Xp54nrb is not expressed in the ciliary marginal zone, or in the lens. In a more posterior position, Xp54nrb expression is only detected in the spinal cord, and the staining is clearly restricted to the ventricular zone (Fig. 6D) , where the undifferentiated neural progenitors proliferate. Thus, during Xenopus development, the expression pattern of the new RBP mRNA Xp54nrb is associated with the neural and sensorial territories, with an important expression in the retinal structures.
Photomicrographs of whole-mounts and sections through the corresponding whole mounts for stage 23 (A, B) and stage 35 (C-F) embryos are shown. (A) Whole mount and section analysis (B) at stage 23 show Xp54nrb expressed in optic cup (oc), otic vesicle (ov), branchial arches (ba) and mesencephalon (Me) (whole mount, lateral view, anterior is left). (C) Anterior view at stage 35 shows similar labelling patterns to the stage 23 embryo with neuroretina, encephalon and spinal chord labelled. (D) In the transverse section at the trunk level, only the ventricular zone of the spinal cord is stained (white arrowheads). (E) Section at the head level through the eye (F), enlargement of E) the dorsal part of the spinal chord, and the inner layer of the neuroretina are labelled. No staining is detected in the lens or in the ciliary marginal zone (CMZ, black arrowhead in F
Xp54nrb downregulation affects neural gene expression
While Xp54nrb is expressed all along Xenopus embryogenesis, especially in the neuroectodermal tissues during the early steps of development, we wondered to determine if this RNA binding protein was implicated in the early neurogenesis. To answer this question we have analysed the effects of its loss of function by morpholino injection. We firstly verified by western blot, the specificity of the morpholino directed against Xp54nrb (MoXp54) (Fig. 7A ) and on developing embryo (Fig. 7B) . Co-injections of MoXp54 with the the loss of function does not induce a delay of neural development in the morphants, but a real impairment of neurogenesis.
Xp54nrb morpholino effects are partially rescued by the human p54nrb
Taking account that the 5' sequence of human p54nrb presents 9 mismatches compared to the 25 nucleotides targeted by the morpholino chosen against the Xenopus sequence, we used the human p54nrb for rescue experiments. We firstly verified that the human p54nrb is effectively resistant to Xp54nrb morpholino. Indeed, as shown by western blot (Fig. 7A) as well as by fluorescence detection (Fig. 7B) , the morpholino directed against Xp54nrb does not inhibit translation of the in vitro synthesised mRNA for human p54nrb tagged with GFP, whereas the morpholino efficiently blocks Xp54nrb-GFP expression.
We therefore co-injected Xp54nrb morpholino with mRNA encoding human p54nrb that does not contain the morpholino recognition site and analysed by in situ hybridization the resulting expression pattern on neural markers at stage 17 (Fig. 8) . The human p54nrb is able to restore Sox2 and Zic3 expression ( Fig.  8O ; n=6/11 embryos and Fig. 8N , n=7/12 embryos, respectively) previously affected in morphants. Compared to Pou2 pattern obtained with morpholino treatment, co-injection with human p54nrb allows Pou2 re-expression even with a weak posteriorization shift ( Fig. 8M ; n=5/8 injected embryos).
These data suggest that Xp54nrb is required for neural development, since loss of function by morpholino leads to a reduction of early proneural gene expressions which is restricted to the anterior part of the future central nervous system in Xenopus embryo.
Discussion
In this work, we show, for the first time, the detailed spatial and temporal expression pattern of Xp54nrb during embryonic development in Xenopus laevis. One important point is that Xp54nrb is a Ca 2+ target gene isolated from the cDNA subtractive library and involved in neural induction. This further confirms the essential role played by Ca 2+ during early neurogenesis (Batut et al., 2005) . The expression of Xp54nrb is highly specific, namely early restricted to neural tissue and maintained in the neural progenitors in the ventricular zone. Thus, Xp54nrb is likely associated with neural progeny in undifferentiated state.
Xp54nrb encodes Xenopus homologue of p54nrb/NonO protein, which has multifunctional roles in the nucleus, such as DNA binding protein (Yang et al., 1993) , interaction with the RNA polymerase II (Emili et al., 2002) , association with another RRM-containing protein PSF the polypyrimidine tract-binding protein-associated splicing factor (Shav-Tal and Zipori 2002), modulation of the androgen receptor activity in cell culture (Dong et al., 2007) . It has also been shown that p54nrb acts as transcriptional repressor to regulate Connexin-43 expression when it interacts with the progesterone receptor during the labour (Dong et al., 2009) , or with the Malignant Inhibitor Activity (MIA) in melanoma progression (Schiffner et al., 2011) . Interestingly, (Amelio et al., 2007) showed that p54nrb is implicated in transcription regulation of c-fos mediated by CREB pathway. In addition p54nrb can bind to RNA and function in RNA processing activities in pre-mRNA splicing (Dong et al., 1993; Kameoka et al., 2004) , in polyadenylation steps (Liang and Lutz (MoC, lanes 2, 3, and 4) (Kaneko et al., 2007) . To date, the major in vivo implication of p54nrb in mammals is demonstrated in chondrogenesis where it controls the splicing of the Col2a1 gene in association with the transcription factor Sox9 (Hata et al., 2008) and in cartilage regeneration (Schmid et al., 2010) .
An important point of this work is the specific expression of Xp54nrb mRNA in the inner nuclear cell layer and ganglion cell layer while Xp54nrb does not seem to be expressed in the ciliary marginal zone, or in the lens. Accordingly to Drosophila and mouse patterning, Xp54nrb is notably expressed in eye structures. Loss of function of Xp54nrb affects the expression pattern of pro-neural genes, particularly at the anterior part of the developing central nervous system, from where emerges the neuroretina.
In mouse, p54nrb/NonO itself is regulated by splicing, as it exhibits two transcripts in brain and a third form which is specific of the adult retina (Yang et al., 1993) . In Drosophila melanogaster, two isoforms of NONA/BJ6 are found (Jones and Rubin, 1990 ). This gene is expressed in the ocular structures of the fly and several mutants are described in which the vision is affected (Rendahl et al., 1996) . The Sfrs1 alternative splicing factor, for example, is necessary for murine retina development and retinal neuron survival (Kanadia et al., 2008) . The involvement of several RNA-binding proteins (RBPs) in Xenopus eye development has been also demonstrated for retinal cell fate decision (Boy et al., 2004) . Furthermore, the expression patterns of five neural RNA binding proteins belonging to different RBP families, showed distinct spatial-temporal distributions in the multilayered retina in Xenopus laevis (Amato et al., 2005) . The authors suggested that these posttranscriptional regulators may play important roles in the multiple steps occurring for cell-type specification and/or differentiation during retinogenesis.
In this study, we show that Xp54nrb transcription exhibits a typical neural specificity of expression throughout Xenopus early development, and its presence is required for the correct patterning of the anterior neural structures. Furthermore Xp54nrb is a calcium target gene. Whether its regulation by Ca 2+ is direct or indirect remains a mechanism to be investigated.
Materials and Methods
Animals and explanted animal caps
Xenopus laevis eggs are collected, fertilized, and embryos are cultured by standard procedures (Batut et al., 2005) . Embryos are staged according to (Nieuwkoop and Faber 1967) . Animal caps are dissected in 0.5 x NAM from stage 8-9 embryos, preincubated for 30 minutes with the calcium chelator BAPTA-AM (20 mM) prior to incubation with noggin protein (2 mg/ mL) and cultured until sibling embryo reached to stage 12.
Xp54nrb cloning
A subtractive library (PCR-Select cDNA Subtraction kit, Clontech) was constructed between untreated animal caps and animal caps neuralized by caffeine-triggered Ca 2+ release (Batut et al., 2003; Batut et al., 2005) . A 820 bp-long fragment (3F4) was isolated and used to screen in silico libraries. Two complete cDNA exhibited perfect homology in their 3'UTR part with the 3F4 sequence, one isolated from stage 31-32 cDNA library (Klein et al., 2002) corresponds to the accession number BC045128, and the second issued from a systematic screen of anterior genes library (Takahashi et al., 2005) is referred under the accession number AB238228. The full length cDNA BC045128 was purchased from RZPD Consortium, Germany (http://image.llnl.gov).
Morpholino
Morpholino oligonucleotide (GeneTools, Corvalis, USA) was designed to block translation of X. laevis p54nrb. The sequence enclosed the AUG start codon (in bold): GTACCCTCTGTTTCCCTGCATGTTT. The standard control Morpholino (MoC) was provided by the manufactor. Typically 4 ng of Morpholinos per embryo are injected in the presence of in vitro-synthesized nuclear b-galactosidase mRNA (50 pg) as a tracer, revealed at the desired stages of development with the Red-Gal substrate (6-chloro-3-indoyl-b-Dgalactoside, Research Organics).
Plasmid constructs, in vitro transcription for microinjections, GFP detection
For in vivo expression, pCS2-Xp54nrb-GFP was constructed by PCR- amplified ORF of Xp54nrb without stop codon introduced in frame into pCS2-GFP plasmid. The human p54nrb ORF was amplified by PCR from cDNA pool of HeLa cells (a gift from Dr P. Belenguer) and introduced in the pCS2 vector, with or without GFP, in place of Xp54nrb. These construts were linearised at the NotI site, and the capped synthetic mRNAs were generated by using SP6 mMessage mMachine kit (Ambion). Embryos were pressure-injected in one blastomere at the 2-cell to 4-cell stages with GFP, or Xp54nrb-GFP and p54nrb-GFP mRNAs, at 50 pg or 1 ng respectively, and allowed to develop at 22°C. In vivo expression of GFP was imaged on stage 13 embryo using confocal facilities (Leica, TCS SP5, TRI platform, Toulouse). The nuclei were stained by pre-incubating the embryos 1 hour with 10 mM DRAQ5 (BioStatus Ldt, UK).
For western blot analysis, control and microinjected embryos were lysed at stage 13 (lysis buffer: 20 mM Tris pH 7.5, 2 mM MgCl 2 , 1 mM EDTA, 10 mM NaF, 1 mM DTT, 0.5% NP40) and 10K supernatants equivalent to 1 embryo, were applied on SDS-PAGE. The GFP and GFP-tagged proteins were revealed by immunoblotting with rabbit anti-GFP polyclonal antibody (1/3000, TP401, Torrey Pines, Biolabs), Goat peroxidase-conjugated anti-rabbit antibody (1/5000, Promega) was detected with the enhanced chemiluminescent kit (ECL, Amersham).
RT-PCR and in situ hybridization
Extraction of total RNA, Reverse-Transcription and PCR assays with primer sets for ODC, Xbra and Zic3 were performed as described (Batut et al., 2003) . Pax3 primer set is according to Xenopus Molecular Marker Resources, Slug primers to (Aybar et al., 2003) . We designed the following primers for Xp54nrb: Forward (at 1511 bp) 5'-AGGTCAGTCTCTAGTG-CAGATGG-3' and Reverse (at 1671 bp) 5'-AACGGACAGTATACTAC-GACTGG-3'. RT-PCR analyses with these primers were performed for 32 cycles (thermocycler Flexigene, Techne). The absence of genomic contamination was systematically checked with ODC amplification of the RNA samples without reverse transcriptase. Similar results were obtained from three independent experiments in each assay.
Whole-mount in situ hybridization (ISH) was carried out according to (Harland 1991) . Antisense RNA digoxigenin-labeled probes were synthesized by using cDNA templates encoding POU2 (Witta et al., 1995) , Sox2 (Mizuseki et al., 1998) and Zic3 (Nakata et al., 1997) . For Xp54nrb ISH, we used the complete cDNA as a template. For Xp54nrb antisense, the vector was linearised at the KpnI site and transcribed by using the T7 promoter. The sense probe was obtained by SP6 transcription after NotI linearization. For histology, stained embryos were embedded in 3% agarose and sectioned on a vibratome at 70 mm.
